Trials / Completed
CompletedNCT01788449
Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance
Association of Antibiotic Measures and Control of Bacterial Resistance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 335 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Assess efficacy of piperacillin/tazobactam in reducing the cases of colonization and infection of bacteria.
Detailed description
Primarily, this study is designed to assess the efficacy of piperacillin/tazobactam in reducing the cases of colonization and infection of extended-spectrum betalactamases (ESBLs) producing E.coli or K pneumoniae, S aureus methicillin resistant (MRSA) and Enterococcus vancomycin resistant (VRE). Secondly, this study plans to determine the acquisition rate of ESBL producing E Coli or K pneumoniae, methicillin resistant S Aureus (MRSA) and vancomycin resistant Enterococcus spp (VRE), both pre- and post-intervention.
Conditions
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2013-02-11
- Last updated
- 2013-02-13
Source: ClinicalTrials.gov record NCT01788449. Inclusion in this directory is not an endorsement.